Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Changjun Liu

Showing results (191-200 of 216) with videos related to

Pageof 22
Sort By:
Microbial Cell Factories|February 2, 2019
Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virusWenqian Wang, Yuxin Song, Linlin Liu, et al.
Virology|April 27, 2018
Avian leukosis virus subgroup J promotes cell proliferation and cell cycle progression through miR-221 by targeting CDKN1BChaoqi Ren, Mengmeng Yu, Yao Zhang, et al.
Viruses|March 26, 2015
Chondroitin sulfate N-acetylgalactosaminyltransferase-2 contributes to the replication of infectious bursal disease virus via interaction with the capsid protein VP2Lizhou Zhang, Xiangang Ren, Yuming Chen, et al.
Journal of Virology|September 11, 2025
A recombinant Marek's disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickensWenrui Fan, Xianying Zeng, Yuntong Chen, et al.
Veterinary Microbiology|March 5, 2019
Novel variant strains of infectious bursal disease virus isolated in ChinaLinjin Fan, Tiantian Wu, Altaf Hussain, et al.
Transboundary and Emerging Diseases|April 30, 2025
A Single Mutation of VP2 is Responsible for the Lethality and Antigenicity Differences between Novel Variant and Very Virulent IBDV StrainsNan Jiang, Guodong Wang, Wenying Zhang, et al.
Frontiers in Microbiology|October 22, 2019
Macrophage Migration Inhibitory Factor Triggers Inflammatory Responses During Very Virulent Infectious Bursal Disease Virus InfectionAijing Liu, Hui Li, Xiaole Qi, et al.
Applied Microbiology and Biotechnology|January 5, 2020
Development and evaluation of a gp85 protein-based subgroup-specific indirect enzyme-linked immunosorbent assay for the detection of anti-subgroup J avian leukosis virus antibodiesFangfang Chang, Lixiao Xing, Zhifeng Xing, et al.
Journal of Virology|September 7, 2022
Residues L55 and W69 of Tva Mediate Entry of Subgroup A Avian Leukosis VirusYuntong Chen, Suyan Wang, Xinyi Li, et al.
Frontiers in Microbiology|August 15, 2022
Residues 318 and 323 in capsid protein are involved in immune circumvention of the atypical epizootic infection of infectious bursal disease virusLinjin Fan, Yulong Wang, Nan Jiang, et al.
Pageof 22

Showing results (191-200 of 216) with videos related to

Sort By:
Pageof 22
Microbial Cell Factories|February 2, 2019
Neutralizing-antibody-mediated protection of chickens against infectious bursal disease via one-time vaccination with inactivated recombinant Lactococcus lactis expressing a fusion protein constructed from the RCK protein of Salmonella enterica and VP2 of infectious bursal disease virusWenqian Wang, Yuxin Song, Linlin Liu, et al.
Virology|April 27, 2018
Avian leukosis virus subgroup J promotes cell proliferation and cell cycle progression through miR-221 by targeting CDKN1BChaoqi Ren, Mengmeng Yu, Yao Zhang, et al.
Viruses|March 26, 2015
Chondroitin sulfate N-acetylgalactosaminyltransferase-2 contributes to the replication of infectious bursal disease virus via interaction with the capsid protein VP2Lizhou Zhang, Xiangang Ren, Yuming Chen, et al.
Journal of Virology|September 11, 2025
A recombinant Marek's disease vaccine candidate provides complete protection against infectious bursal disease virus and H9 subtype avian influenza virus in chickensWenrui Fan, Xianying Zeng, Yuntong Chen, et al.
Veterinary Microbiology|March 5, 2019
Novel variant strains of infectious bursal disease virus isolated in ChinaLinjin Fan, Tiantian Wu, Altaf Hussain, et al.
Transboundary and Emerging Diseases|April 30, 2025
A Single Mutation of VP2 is Responsible for the Lethality and Antigenicity Differences between Novel Variant and Very Virulent IBDV StrainsNan Jiang, Guodong Wang, Wenying Zhang, et al.
Frontiers in Microbiology|October 22, 2019
Macrophage Migration Inhibitory Factor Triggers Inflammatory Responses During Very Virulent Infectious Bursal Disease Virus InfectionAijing Liu, Hui Li, Xiaole Qi, et al.
Applied Microbiology and Biotechnology|January 5, 2020
Development and evaluation of a gp85 protein-based subgroup-specific indirect enzyme-linked immunosorbent assay for the detection of anti-subgroup J avian leukosis virus antibodiesFangfang Chang, Lixiao Xing, Zhifeng Xing, et al.
Journal of Virology|September 7, 2022
Residues L55 and W69 of Tva Mediate Entry of Subgroup A Avian Leukosis VirusYuntong Chen, Suyan Wang, Xinyi Li, et al.
Frontiers in Microbiology|August 15, 2022
Residues 318 and 323 in capsid protein are involved in immune circumvention of the atypical epizootic infection of infectious bursal disease virusLinjin Fan, Yulong Wang, Nan Jiang, et al.
Pageof 22